ScholarIQanswers from OpenAlex

Folate-Conjugated Rapamycin Slows Progression of Polycystic Kidney Disease

PaperCitations, authors & open-access status

Folate-Conjugated Rapamycin Slows Progression of Polycystic Kidney Disease is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Folate-Conjugated Rapamycin Slows Progression of Polycystic Kidney Disease have?

ScholarIQcitation count

Folate-Conjugated Rapamycin Slows Progression of Polycystic Kidney Disease has 101 citations in the OpenAlex counts ScholarIQ stores.

When was Folate-Conjugated Rapamycin Slows Progression of Polycystic Kidney Disease published?

ScholarIQyear

Folate-Conjugated Rapamycin Slows Progression of Polycystic Kidney Disease has 2012 year in the ScholarIQ index.

What is the open-access status of Folate-Conjugated Rapamycin Slows Progression of Polycystic Kidney Disease?

ScholarIQoa status

Folate-Conjugated Rapamycin Slows Progression of Polycystic Kidney Disease has bronze oa status in the ScholarIQ index.

What is the DOI of Folate-Conjugated Rapamycin Slows Progression of Polycystic Kidney Disease?

ScholarIQdoi

The DOI for Folate-Conjugated Rapamycin Slows Progression of Polycystic Kidney Disease is on the source record.

What is the PMID of Folate-Conjugated Rapamycin Slows Progression of Polycystic Kidney Disease?

ScholarIQpmid

The PMID for Folate-Conjugated Rapamycin Slows Progression of Polycystic Kidney Disease is on the source record.

What is the OpenAlex record for Folate-Conjugated Rapamycin Slows Progression of Polycystic Kidney Disease?

ScholarIQopenalex

The OpenAlex for Folate-Conjugated Rapamycin Slows Progression of Polycystic Kidney Disease is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial